CARE Ratings · NSE: CARERATING · BSE: 534804

Q4 FY26 results · Jan–Mar 2026

CARE Ratings reported revenue from operations of ₹130.67 crore (up 19.2% from Q4 FY25) and net profit of ₹53.45 crore (up 23.2% from Q4 FY25) for Q4 FY26 (Jan–Mar 2026), on a consolidated basis.

Consolidated · ₹ crore
ItemQ4 FY26Q4 FY25YoYQ3 FY26QoQ
Revenue from operations130.67109.65+19.2%112.12+16.5%
Other income15.7115.17+3.5%12.99+20.9%
Total income146.38124.82+17.3%125.11+17.0%
Profit before tax72.0158.89+22.3%48.99+47.0%
Net profit for the period53.4543.37+23.2%36.54+46.3%
Attributable to shareholders of the company52.8342.61+24.0%35.90+47.2%
EPS, basic (₹)17.5814.24+23.5%11.96+47.0%
Net margin (%)40.939.632.6
Standalone · ₹ crore
ItemQ4 FY26Q4 FY25YoYQ3 FY26QoQ
Revenue from operations107.5891.24+17.9%90.24+19.2%
Other income15.3915.51−0.8%13.16+17.0%
Total income122.97106.75+15.2%103.40+18.9%
Profit before tax70.5858.93+19.8%47.70+47.9%
Net profit for the period53.3944.88+18.9%36.06+48.1%
EPS, basic (₹)17.7715.00+18.5%12.01+48.0%
Net margin (%)49.649.240.0
Consolidated
Filed with BSE
13 May 2026, 21:52 IST
Board meeting
13 May 2026
Period
01 Jan 2026 to 31 Mar 2026
Review status
Unaudited
Source
XBRL filing on BSE
Standalone
Filed with BSE
13 May 2026, 21:52 IST
Board meeting
13 May 2026
Period
01 Jan 2026 to 31 Mar 2026
Review status
Unaudited
Source
XBRL filing on BSE